Authors' reply to Comment on "External Validation of the Core Obesity Model to Assess the Cost-Effectiveness of Weight Management Interventions"
Pharmacoeconomics
.
2021 Jan;39(1):137-138.
doi: 10.1007/s40273-020-00982-8.
Epub 2020 Nov 30.
Authors
Sandra Lopes
1
,
Pierre Johansen
2
,
Mark Lamotte
3
,
Phil McEwan
4
,
Anamaria-Vera Olivieri
5
,
Volker Foos
4
Affiliations
1
Novo Nordisk A/S, Søborg, Denmark.
[email protected]
.
2
Novo Nordisk A/S, Søborg, Denmark.
3
IQVIA, Zaventem, Belgium.
4
Health Economics and Outcomes Research Ltd, Cardiff, UK.
5
IQVIA, Basel, Switzerland.
PMID:
33251570
PMCID:
PMC7790775
DOI:
10.1007/s40273-020-00982-8
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Kommentar
MeSH terms
Cost-Benefit Analysis
Humans
Obesity* / therapy